image credit: pixabay
Attackers are looking to the healthcare space as a rich repository of intellectual property (IP) now more than ever, as critical research of COVID-19 therapeutics are developed and Pfizer, Moderna and other biotech firms begin to mass produce vaccines. Several incidents show that nation-states are targeting these companies with a vengeance, as the quest to beat the pandemic continues.
Comments are closed.
